INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 March 2014
Total net assets |
£190m |
NAV per share |
344.8p |
Share price |
280.5p |
Total value of unquoted investments |
£26m |
Total number of portfolio companies |
99 |
Top Ten Holdings
Company Name |
% NAV |
Biogen |
7.2 |
Gilead |
6.6 |
Alexion |
6.3 |
Celgene |
5.4 |
Amgen |
4.2 |
Regeneron |
4.0 |
Illumina |
3.2 |
Vertex |
3.0 |
Aptiv |
3.0 |
Mylan |
3.0 |
|
----------- |
Total |
45.9 |
Trust Characteristics |
% NAV |
Profitable |
57 |
Turning Profitable 2015 |
10 |
Unprofitable |
33 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
United States & Canada |
91 |
Europe & UK |
9 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% NAV |
Quoted |
87 |
Unquoted |
13 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
14 APRIL 2014